Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

NCT06185751 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: WS-CART-CS1
DRUG: Lymphodepleting chemotherapy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]